Washington University Therapeutics CRS — St Louis, Missouri

Washington University Therapeutics CRS is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Washington University Therapeutics CRS has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: HIV-1-infection, SARS-CoV-2 Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University Therapeutics CRS?

Washington University Therapeutics CRS has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University Therapeutics CRS conducted?

Washington University Therapeutics CRS has 2 clinical trials on record, with 1 currently active. Their work covers HIV-1-infection, SARS-CoV-2 Infection.

Is Washington University Therapeutics CRS accredited by Crixeo Health?

Washington University Therapeutics CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University Therapeutics CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.